Delivery Order SPE2DB20D3103-SPE2DB23FM1Z9
Award Date 1/19/23
Potential Completion Date 2/9/23
Potential Value $17K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Zoladex 10.8 mg implant syringes to the Defense Logistics Agency (DLA). The $36,845.76 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 8, 2024, with a completion date of August 29, 2024. The contract is a delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of the pharmaceutical product Zoladex 10.8 mg implant syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a potential ceiling value of $5,445.66. The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 30, 2024. AmerisourceBergen...
- This federal contract award is for the delivery of Zoladex 10.8 mg Implant Syringes to the Defense Logistics Agency (DLA). The $1,691.96 delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 1, 2023. The contract has a firm fixed price pricing type and an ultimate completion date of September 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Zoladex 3.6 MG Implant Syringes. The $1,873.74 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued up to...
- The Defense Logistics Agency awarded a delivery order valued at $9,297.50 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This contract, awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zoladex is a hormone treatment used...
- The Defense Logistics Agency awarded a delivery order valued at $23,515.44 to AmerisourceBergen Drug Corp for the supply of Zoladex 10.8 mg implant syringes. This firm fixed price contract was competitively awarded without set-aside designation and carries an ultimate completion date of December 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order represents a child contract under...
- This federal contract award, valued at $1,292.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS, a specialty medication. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,527.36 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,336.98 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS medical products. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,249.20 firm fixed price contract is for the delivery of the medication Zoladex 3.6 mg implant syringes, with a completion date of November 5, 2024. Amerisourcebergen provides a broad range of pharmaceutical and medical supplies to federal agencies through various Indefinite Delivery Contracts (IDCs), including a...